IPCALAB - IPCA Laboratories Limited

IPCA Laboratories Limited Share Market Related News
-: Stock News :- IPCALAB 17-06-2022 To 17-06-2022
-: Stock News :- IPCALAB 17-06-2022 To 17-06-2022

✔️ Broker's Call: Ipca Laboratories (Buy)

View Full Story
-: Stock News :- IPCALAB 30-05-2022 To 30-05-2022
-: Stock News :- IPCALAB 30-05-2022 To 30-05-2022

✔️ Hold Ipca Laboratories : target of Rs 1080: Sharekhan
✔️ IPCA Labs: Growth outlook primed by domestic business

View Full Story
-: Stock News :- IPCALAB 24-05-2022 To 30-05-2022
-: Stock News :- IPCALAB 24-05-2022 To 30-05-2022

✔️ Ipca Labs Q4 net profit declines 19% at Rs 130 crore on higher expenses
✔️ IPCA Labs: Growth outlook primed by domestic business

View Full Story
-: Stock News :- IPCALAB 14-04-2022 To 30-05-2022
-: Stock News :- IPCALAB 14-04-2022 To 30-05-2022

✔️ Ipca Laboratories Q4 PAT may dip 12% YoY to Rs 141.9 cr: Prabhudas Lilladher
✔️ IPCA Labs: Growth outlook primed by domestic business

View Full Story
-: Stock News :- IPCALAB 14-03-2022 To 30-05-2022
-: Stock News :- IPCALAB 14-03-2022 To 30-05-2022

✔️ Buy Ipca Labs; target of Rs 1200 : Motilal Oswal
✔️ IPCA Labs: Growth outlook primed by domestic business

View Full Story
-: Stock News :- IPCALAB 21-02-2022 To 21-02-2022
-: Stock News :- IPCALAB 21-02-2022 To 21-02-2022

✔️ Pain likely to continue for Ipca Laboratories
✔️ Buy Ipca Laboratories; target of Rs 1175: ICICI Direct

View Full Story
-: Stock News :- IPCALAB 18-02-2022 To 21-02-2022
-: Stock News :- IPCALAB 18-02-2022 To 21-02-2022

✔️ Buy IPCA Laboratories; target of Rs 1160: Sharekhan
✔️ Buy Ipca Laboratories; target of Rs 1175: ICICI Direct

View Full Story
-: Stock News :- IPCALAB 17-02-2022 To 16-02-2022
-: Stock News :- IPCALAB 17-02-2022 To 16-02-2022

✔️ Buy Ipca Laboratories; target of Rs 1190: Motilal Oswal
✔️ Ipca Labs Consolidated December 2021 Net Sales at Rs 1,430.47 crore, up 1.46% Y-o-Y
✔️ Hold IPCA Laboratories; target of Rs 1060: Emkay Global Financial
✔️ Buy Ipca Laboratories; target of Rs 1225: Prabhudas Lilladher
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 14-02-2022 To 16-02-2022
-: Stock News :- IPCALAB 14-02-2022 To 16-02-2022

✔️ Ipca Laboratories' PAT declines 26% to Rs 199.9 crore in December quarter
✔️ Ipca Labs Consolidated December 2021 Net Sales at Rs 1,430.47 crore, up 1.46% Y-o-Y
✔️ Hold IPCA Laboratories; target of Rs 1060: Emkay Global Financial
✔️ Buy Ipca Laboratories; target of Rs 1225: Prabhudas Lilladher
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 13-01-2022 To 16-02-2022
-: Stock News :- IPCALAB 13-01-2022 To 16-02-2022

✔️ Ipca Laboratories Q3 PAT may dip 32.4% YoY to Rs 179.6 cr: Prabhudas Lilladher
✔️ Ipca Labs Consolidated December 2021 Net Sales at Rs 1,430.47 crore, up 1.46% Y-o-Y
✔️ Hold IPCA Laboratories; target of Rs 1060: Emkay Global Financial
✔️ Buy Ipca Laboratories; target of Rs 1225: Prabhudas Lilladher
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 10-01-2022 To 16-02-2022
-: Stock News :- IPCALAB 10-01-2022 To 16-02-2022

✔️ Ipca Labs down 6% as stock turns ex-date for 1:1 split
✔️ Ipca Labs Consolidated December 2021 Net Sales at Rs 1,430.47 crore, up 1.46% Y-o-Y
✔️ Hold IPCA Laboratories; target of Rs 1060: Emkay Global Financial
✔️ Buy Ipca Laboratories; target of Rs 1225: Prabhudas Lilladher
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 03-12-2021 To 16-02-2022
-: Stock News :- IPCALAB 03-12-2021 To 16-02-2022

✔️ Buy Ipca Laboratories; target of Rs 2530: Edelweiss Securities
✔️ Ipca Labs Consolidated December 2021 Net Sales at Rs 1,430.47 crore, up 1.46% Y-o-Y
✔️ Hold IPCA Laboratories; target of Rs 1060: Emkay Global Financial
✔️ Buy Ipca Laboratories; target of Rs 1225: Prabhudas Lilladher
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 25-11-2021 To 16-02-2022
-: Stock News :- IPCALAB 25-11-2021 To 16-02-2022

✔️ Buy Ipca Laboratories: target of Rs 2675: Sharekhan
✔️ Ipca Laboratories to pick up 26.57% stake in Lyka for 97.89 cr
✔️ Ipca Labs approves 26.57% stake acquisition in Lyka Labs
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 19-11-2021 To 16-02-2022
-: Stock News :- IPCALAB 19-11-2021 To 16-02-2022

✔️ IPCA Labs: weak exports, API sales, rising costs pose near term challenges
✔️ Ipca Laboratories to pick up 26.57% stake in Lyka for 97.89 cr
✔️ Ipca Labs approves 26.57% stake acquisition in Lyka Labs
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 18-11-2021 To 16-02-2022
-: Stock News :- IPCALAB 18-11-2021 To 16-02-2022

✔️ IPCA Labs: Domestic beat offsets API weakness
✔️ Ipca Laboratories to pick up 26.57% stake in Lyka for 97.89 cr
✔️ Ipca Labs approves 26.57% stake acquisition in Lyka Labs
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 17-11-2021 To 16-02-2022
-: Stock News :- IPCALAB 17-11-2021 To 16-02-2022

✔️ Buy Ipca Laboratories; target of Rs 2450: Prabhudas Lilladher
✔️ Brokerages see 16% upside in Ipca Labs despite fall in Q2 profit, margin headwinds
✔️ Ipca Labs approves 26.57% stake acquisition in Lyka Labs
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 13-11-2021 To 16-02-2022
-: Stock News :- IPCALAB 13-11-2021 To 16-02-2022

✔️ Ipca Labs' Jul-Sep net profit declines 6% to Rs 250 crore
✔️ Ipca Laboratories Q2 net profit declines 6% to Rs 250 crore
✔️ Ipca Labs second quarter net profit declines 6% to Rs 250 crore
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 20-10-2021 To 16-02-2022
-: Stock News :- IPCALAB 20-10-2021 To 16-02-2022

✔️ Ipca Labs board to consider 1:2 stock split on November 13
✔️ Ipca Laboratories Q2 net profit declines 6% to Rs 250 crore
✔️ Ipca Labs second quarter net profit declines 6% to Rs 250 crore
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 06-10-2021 To 16-02-2022
-: Stock News :- IPCALAB 06-10-2021 To 16-02-2022

✔️ Ipca Laboratories Q2 PAT seen up 7.3% YoY to Rs 292.6 cr: Prabhudas Lilladher
✔️ Ipca Laboratories Q2 net profit declines 6% to Rs 250 crore
✔️ Ipca Labs second quarter net profit declines 6% to Rs 250 crore
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 13-09-2021 To 16-02-2022
-: Stock News :- IPCALAB 13-09-2021 To 16-02-2022

✔️ Buy Ipca Laboratories: target of Rs 2850: Sharekhan
✔️ Ipca Laboratories Q2 net profit declines 6% to Rs 250 crore
✔️ Ipca Labs second quarter net profit declines 6% to Rs 250 crore
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 07-09-2021 To 16-02-2022
-: Stock News :- IPCALAB 07-09-2021 To 16-02-2022

✔️ IPCA Labs leads top 10 Indian pharma companies in August
✔️ Ipca Laboratories Q2 net profit declines 6% to Rs 250 crore
✔️ Ipca Labs second quarter net profit declines 6% to Rs 250 crore
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 10-08-2021 To 16-02-2022
-: Stock News :- IPCALAB 10-08-2021 To 16-02-2022

✔️ Buy Ipca Laboratories; target of Rs 2560: ICICI Direct
✔️ Ipca Laboratories Q2 net profit declines 6% to Rs 250 crore
✔️ Ipca Labs second quarter net profit declines 6% to Rs 250 crore
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 09-08-2021 To 16-02-2022
-: Stock News :- IPCALAB 09-08-2021 To 16-02-2022

✔️ IPCA Labs: Strong revival for domestic formulations
✔️ Ipca Laboratories Q2 net profit declines 6% to Rs 250 crore
✔️ Ipca Labs second quarter net profit declines 6% to Rs 250 crore
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 05-08-2021 To 16-02-2022
-: Stock News :- IPCALAB 05-08-2021 To 16-02-2022

✔️ Ipca Labs Consolidated June 2021 Net Sales at Rs 1,565.79 crore, up 2.05% Y-o-Y
✔️ Ipca Laboratories Q2 net profit declines 6% to Rs 250 crore
✔️ Ipca Labs second quarter net profit declines 6% to Rs 250 crore
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 05-07-2021 To 16-02-2022
-: Stock News :- IPCALAB 05-07-2021 To 16-02-2022

✔️ IPCA Labs’ domestic formulations business to drive growth
✔️ Ipca Laboratories Q2 net profit declines 6% to Rs 250 crore
✔️ Ipca Labs second quarter net profit declines 6% to Rs 250 crore
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 02-06-2021 To 16-02-2022
-: Stock News :- IPCALAB 02-06-2021 To 16-02-2022

✔️ IPCA Labs: Strong margins to sustain even post-COVID opportunities
✔️ Ipca Laboratories Q2 net profit declines 6% to Rs 250 crore
✔️ Ipca Labs second quarter net profit declines 6% to Rs 250 crore
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 01-06-2021 To 16-02-2022
-: Stock News :- IPCALAB 01-06-2021 To 16-02-2022

✔️ Buy Ipca Laboratories; target of Rs 2400: Motilal Oswal
✔️ Buy Ipca Laboratories: target of Rs 2560: Sharekhan
✔️ Ipca Labs second quarter net profit declines 6% to Rs 250 crore
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 31-05-2021 To 16-02-2022
-: Stock News :- IPCALAB 31-05-2021 To 16-02-2022

✔️ High base of Q4 led to a weak Q4 show for IPCA: FY22 guidance though encourages
✔️ Buy Ipca Laboratories: target of Rs 2560: Sharekhan
✔️ Ipca Labs second quarter net profit declines 6% to Rs 250 crore
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 28-05-2021 To 16-02-2022
-: Stock News :- IPCALAB 28-05-2021 To 16-02-2022

✔️ Drug firm Ipca Laboratories fourth quarter profit up 94% at Rs 161 crore
✔️ Buy Ipca Laboratories: target of Rs 2560: Sharekhan
✔️ Ipca Labs second quarter net profit declines 6% to Rs 250 crore
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 16-04-2021 To 16-02-2022
-: Stock News :- IPCALAB 16-04-2021 To 16-02-2022

✔️ Firm domestic growth, export prospects keep street positive on Ipca Laboratories
✔️ Buy Ipca Laboratories: target of Rs 2560: Sharekhan
✔️ Ipca Labs second quarter net profit declines 6% to Rs 250 crore
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 15-04-2021 To 16-02-2022
-: Stock News :- IPCALAB 15-04-2021 To 16-02-2022

✔️ Ipca Laboratories (2,159): Buy
✔️ Buy Ipca Laboratories: target of Rs 2560: Sharekhan
✔️ Ipca Labs second quarter net profit declines 6% to Rs 250 crore
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 12-04-2021 To 16-02-2022
-: Stock News :- IPCALAB 12-04-2021 To 16-02-2022

✔️ Broker's call: Ipca Lab (Buy)
✔️ Buy Ipca Laboratories; target of Rs 2480: Motilal Oswal
✔️ Ipca Labs second quarter net profit declines 6% to Rs 250 crore
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 19-03-2021 To 16-02-2022
-: Stock News :- IPCALAB 19-03-2021 To 16-02-2022

✔️ Buy Ipca Laboratories: target of Rs 2560: Sharekhan
✔️ Buy Ipca Laboratories; target of Rs 2480: Motilal Oswal
✔️ Ipca Labs second quarter net profit declines 6% to Rs 250 crore
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 10-02-2021 To 16-02-2022
-: Stock News :- IPCALAB 10-02-2021 To 16-02-2022

✔️ Buy Ipca Laboratories; target of Rs 2490: ICICI Direct
✔️ Buy Ipca Laboratories; target of Rs 2480: Motilal Oswal
✔️ Ipca Labs second quarter net profit declines 6% to Rs 250 crore
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 08-02-2021 To 16-02-2022
-: Stock News :- IPCALAB 08-02-2021 To 16-02-2022

✔️ IPCA Labs: API capacity constraint almost out of the way
✔️ Buy Ipca Laboratories; target of Rs 2480: Motilal Oswal
✔️ Ipca Labs second quarter net profit declines 6% to Rs 250 crore
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 04-02-2021 To 16-02-2022
-: Stock News :- IPCALAB 04-02-2021 To 16-02-2022

✔️ Ipca Laboratories Q3 net profit rises 35% to Rs 267.56 crore
✔️ Ipca Labs Standalone December 2020 Net Sales at Rs 1,315.22 crore, up 15.46% Y-o-Y
✔️ Ipca Labs Consolidated December 2020 Net Sales at Rs 1,409.83 crore, up 16.24% Y-o-Y
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 22-01-2021 To 16-02-2022
-: Stock News :- IPCALAB 22-01-2021 To 16-02-2022

✔️ Ipca Labs Q3 PAT seen up 4.9% YoY to Rs. 207.2 cr: Yash Securities
✔️ Ipca Labs Standalone December 2020 Net Sales at Rs 1,315.22 crore, up 15.46% Y-o-Y
✔️ Ipca Labs Consolidated December 2020 Net Sales at Rs 1,409.83 crore, up 16.24% Y-o-Y
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 15-01-2021 To 16-02-2022
-: Stock News :- IPCALAB 15-01-2021 To 16-02-2022

✔️ Weekly Tactical Pick: IPCA Labs Outperforms in domestic formulations market
✔️ Ipca Labs Standalone December 2020 Net Sales at Rs 1,315.22 crore, up 15.46% Y-o-Y
✔️ Ipca Labs Consolidated December 2020 Net Sales at Rs 1,409.83 crore, up 16.24% Y-o-Y
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 13-11-2020 To 16-02-2022
-: Stock News :- IPCALAB 13-11-2020 To 16-02-2022

✔️ Buy Ipca Laboratories; target of Rs 2680: Motilal Oswal
✔️ Ipca Labs Standalone December 2020 Net Sales at Rs 1,315.22 crore, up 15.46% Y-o-Y
✔️ Ipca Labs Consolidated December 2020 Net Sales at Rs 1,409.83 crore, up 16.24% Y-o-Y
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 12-11-2020 To 16-02-2022
-: Stock News :- IPCALAB 12-11-2020 To 16-02-2022

✔️ Buy Ipca Laboratories: target of Rs 2665: ICICI Direct
✔️ Hold Ipca Laboratories; target of Rs 2393: Prabhudas Lilladher
✔️ Accumulate IPCA Laboratories; target of Rs 2369: Dolat Capital Market
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 10-11-2020 To 16-02-2022
-: Stock News :- IPCALAB 10-11-2020 To 16-02-2022

✔️ IPCA Labs: Is vaccine anti-thesis to the pharma rally?
✔️ Hold Ipca Laboratories; target of Rs 2393: Prabhudas Lilladher
✔️ Accumulate IPCA Laboratories; target of Rs 2369: Dolat Capital Market
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 07-11-2020 To 16-02-2022
-: Stock News :- IPCALAB 07-11-2020 To 16-02-2022

✔️ Ipca Laboratories Q2 profit up 38% at Rs 267 crore
✔️ Ipca Labs Q2 profit up 38 per cent at Rs 267 cr
✔️ Accumulate IPCA Laboratories; target of Rs 2369: Dolat Capital Market
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 27-10-2020 To 16-02-2022
-: Stock News :- IPCALAB 27-10-2020 To 16-02-2022

✔️ Ipca Labs rallies 9%, hits all-time high on hopes of healthy Q2 results
✔️ Ipca Labs Q2 profit up 38 per cent at Rs 267 cr
✔️ Accumulate IPCA Laboratories; target of Rs 2369: Dolat Capital Market
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 20-10-2020 To 16-02-2022
-: Stock News :- IPCALAB 20-10-2020 To 16-02-2022

✔️ These 12 companies see profit growth of more than 500% over last 5 fiscal years
✔️ Ipca Labs Q2 profit up 38 per cent at Rs 267 cr
✔️ Accumulate IPCA Laboratories; target of Rs 2369: Dolat Capital Market
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 08-09-2020 To 16-02-2022
-: Stock News :- IPCALAB 08-09-2020 To 16-02-2022

✔️ Going digital: Ipca Laboratories ties up with Dassault Systemes for ONE Lab' solutions
✔️ Ipca Labs Q2 profit up 38 per cent at Rs 267 cr
✔️ Accumulate IPCA Laboratories; target of Rs 2369: Dolat Capital Market
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 16-08-2020 To 16-02-2022
-: Stock News :- IPCALAB 16-08-2020 To 16-02-2022

✔️ In process of obtaining environmental clearance for new plant in MP: Ipca
✔️ Ipca Labs Q2 profit up 38 per cent at Rs 267 cr
✔️ Accumulate IPCA Laboratories; target of Rs 2369: Dolat Capital Market
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 14-08-2020 To 16-02-2022
-: Stock News :- IPCALAB 14-08-2020 To 16-02-2022

✔️ Buy IPCA Labs; target of Rs 2300: Anand Rathi
✔️ Ipca Labs Q2 profit up 38 per cent at Rs 267 cr
✔️ Accumulate IPCA Laboratories; target of Rs 2369: Dolat Capital Market
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 13-08-2020 To 16-02-2022
-: Stock News :- IPCALAB 13-08-2020 To 16-02-2022

✔️ Buy Ipca Laboratories; target of Rs 2420: Motilal Oswal
✔️ Ipca Labs Q2 profit up 38 per cent at Rs 267 cr
✔️ Accumulate IPCA Laboratories; target of Rs 2369: Dolat Capital Market
✔️ Ipca Labs approves acquisition of 26.5% stake in Lyka Labs
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 12-08-2020 To 16-02-2022
-: Stock News :- IPCALAB 12-08-2020 To 16-02-2022

✔️ Buy Ipca Laboratories; target of Rs 2365: Sharekhan
✔️ Buy Ipca Laboratories; target of Rs 2400: ICICI Direct
✔️ Accumulate IPCA Laboratories ; target of Rs 2106: Dolat Capital
✔️ IPCA Labs: Healthy guidance, look beyond COVID opportunity
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 11-08-2020 To 16-02-2022
-: Stock News :- IPCALAB 11-08-2020 To 16-02-2022

✔️ IPCA's Q1 show decent, but stock prices are riding on a wave of over-optimism
✔️ Ipca Labs Q1 profit jumps more than 3-folds to Rs 445.68 cr on robust sales
✔️ Ipca Labs Consolidated June 2020 Net Sales at Rs 1,534.40 crore, up 42.31% Y-o-Y
✔️ IPCA Labs: Healthy guidance, look beyond COVID opportunity
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 31-07-2020 To 16-02-2022
-: Stock News :- IPCALAB 31-07-2020 To 16-02-2022

✔️ Ipca Lab hits 52-week high in a range-bound market; stk surges 9% in 3 days
✔️ Ipca Labs Q1 profit jumps more than 3-folds to Rs 445.68 cr on robust sales
✔️ Ipca Labs Consolidated June 2020 Net Sales at Rs 1,534.40 crore, up 42.31% Y-o-Y
✔️ IPCA Labs: Healthy guidance, look beyond COVID opportunity
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 06-07-2020 To 16-02-2022
-: Stock News :- IPCALAB 06-07-2020 To 16-02-2022

✔️ IPCA Labs guidance should move investor focus beyond HCQS, accumulate
✔️ Ipca Labs Q1 profit jumps more than 3-folds to Rs 445.68 cr on robust sales
✔️ Ipca Labs Consolidated June 2020 Net Sales at Rs 1,534.40 crore, up 42.31% Y-o-Y
✔️ IPCA Labs: Healthy guidance, look beyond COVID opportunity
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 24-06-2020 To 16-02-2022
-: Stock News :- IPCALAB 24-06-2020 To 16-02-2022

✔️ USFDA has removed partial lifting of import alert on APIs manufacturing facility at Ratlam: Ipca Laboratories
✔️ USFDA has removed partial lifting of import alert on APIs manufacturing facility at Ratlam: Ipca Laboratories
✔️ Ipca Labs Consolidated June 2020 Net Sales at Rs 1,534.40 crore, up 42.31% Y-o-Y
✔️ IPCA Labs: Healthy guidance, look beyond COVID opportunity
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 18-06-2020 To 16-02-2022
-: Stock News :- IPCALAB 18-06-2020 To 16-02-2022

✔️ Buy Ipca Laboratories; target of Rs 1750: Sharekhan
✔️ Buy Ipca Laboratories; target of Rs 1839: Prabhudas Lilladher
✔️ Accumulate IPCA Laboratories; target of Rs 1600: Dolat Capital
✔️ Buy Ipca Laboratories; target of Rs 1900: ICICI Direct
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 17-06-2020 To 16-02-2022
-: Stock News :- IPCALAB 17-06-2020 To 16-02-2022

✔️ Ipca Labs Standalone March 2020 Net Sales at Rs 1,004.79 crore, up 20.51% Y-o-Y
✔️ Domestic market remains a bright spot for Ipca Laboratories in fourth quarter
✔️ Ipca Lab's net profit up by 43% at 652 crore for FY20
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 13-05-2020 To 16-02-2022
-: Stock News :- IPCALAB 13-05-2020 To 16-02-2022

✔️ MSCI India index rejig: Jubilant Food, Ipca Labs among 6 stocks added; 5 scrips removed
✔️ Domestic market remains a bright spot for Ipca Laboratories in fourth quarter
✔️ Ipca Lab's net profit up by 43% at 652 crore for FY20
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 09-04-2020 To 16-02-2022
-: Stock News :- IPCALAB 09-04-2020 To 16-02-2022

✔️ Scenario planning, regular update clause led to export of key drugs
✔️ Domestic market remains a bright spot for Ipca Laboratories in fourth quarter
✔️ Ipca Lab's net profit up by 43% at 652 crore for FY20
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 07-04-2020 To 16-02-2022
-: Stock News :- IPCALAB 07-04-2020 To 16-02-2022

✔️ How IPCA Labs is best suited to reap the hydroxychloroquine opportunity
✔️ Domestic market remains a bright spot for Ipca Laboratories in fourth quarter
✔️ Ipca Lab's net profit up by 43% at 652 crore for FY20
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 23-03-2020 To 16-02-2022
-: Stock News :- IPCALAB 23-03-2020 To 16-02-2022

✔️ Coronavirus impact: Chloroquine demand skyrockets after ICMR recommendation
✔️ Ipca Labs surges as USFDA partially lifts import ban for chloroquine supply
✔️ Ipca Labs share price surges 12% as USFDA partially lifts import ban for chloroquine
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 21-03-2020 To 16-02-2022
-: Stock News :- IPCALAB 21-03-2020 To 16-02-2022

✔️ Covid-19: US FDA partially lifts import ban on Ipca Labs for chloroquine supply
✔️ Ipca Labs surges as USFDA partially lifts import ban for chloroquine supply
✔️ Ipca Labs share price surges 12% as USFDA partially lifts import ban for chloroquine
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 04-03-2020 To 16-02-2022
-: Stock News :- IPCALAB 04-03-2020 To 16-02-2022

✔️ Six stocks hit 52-week highs on NSE
✔️ Ipca Labs surges as USFDA partially lifts import ban for chloroquine supply
✔️ Ipca Labs share price surges 12% as USFDA partially lifts import ban for chloroquine
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 03-03-2020 To 16-02-2022
-: Stock News :- IPCALAB 03-03-2020 To 16-02-2022

✔️ The patient recovers: IPCA bounces back from FDA bans
✔️ Ipca Labs surges as USFDA partially lifts import ban for chloroquine supply
✔️ Ipca Labs share price surges 12% as USFDA partially lifts import ban for chloroquine
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 20-02-2020 To 16-02-2022
-: Stock News :- IPCALAB 20-02-2020 To 16-02-2022

✔️ Buy Ipca Laboratories; target of Rs 1826: Prabhudas Lilladher
✔️ Ipca Labs surges as USFDA partially lifts import ban for chloroquine supply
✔️ Ipca Labs share price surges 12% as USFDA partially lifts import ban for chloroquine
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 14-02-2020 To 16-02-2022
-: Stock News :- IPCALAB 14-02-2020 To 16-02-2022

✔️ Buy Ipca Laboratories target of Rs 1590: Sharekhan
✔️ Ipca Labs Consolidated December 2019 Net Sales at Rs 1,212.86 crore, up 20.55% Y-o-Y
✔️ Ipca Labs share price surges 12% as USFDA partially lifts import ban for chloroquine
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 13-02-2020 To 16-02-2022
-: Stock News :- IPCALAB 13-02-2020 To 16-02-2022

✔️ Result Analyzer: IPCA Laboratories, Hindalco announce results for Q3
✔️ Ipca Labs Consolidated December 2019 Net Sales at Rs 1,212.86 crore, up 20.55% Y-o-Y
✔️ Ipca Labs share price surges 12% as USFDA partially lifts import ban for chloroquine
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 12-02-2020 To 16-02-2022
-: Stock News :- IPCALAB 12-02-2020 To 16-02-2022

✔️ Ipca Labs at record close, up 6% on strong Q3 revenue growth
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54cr
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54 cr
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 18-01-2020 To 16-02-2022
-: Stock News :- IPCALAB 18-01-2020 To 16-02-2022

✔️ Ipca Laboratories has rallied sharply. Should you still buy it?
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54cr
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54 cr
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 13-01-2020 To 16-02-2022
-: Stock News :- IPCALAB 13-01-2020 To 16-02-2022

✔️ Uptick in domestic segment, biz growth continue to drive Ipca Laboratories
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54cr
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54 cr
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 26-12-2019 To 16-02-2022
-: Stock News :- IPCALAB 26-12-2019 To 16-02-2022

✔️ Here's how Ipca Laboratories turned the tide and emerged as an investor's favourite
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54cr
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54 cr
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 11-12-2019 To 16-02-2022
-: Stock News :- IPCALAB 11-12-2019 To 16-02-2022

✔️ IPCA Lab advances 3% on strong fundamentals
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54cr
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54 cr
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 02-12-2019 To 16-02-2022
-: Stock News :- IPCALAB 02-12-2019 To 16-02-2022

✔️ Strong domestic and export growth to drive Ipca Laboratories' earnings
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54cr
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54 cr
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 07-11-2019 To 16-02-2022
-: Stock News :- IPCALAB 07-11-2019 To 16-02-2022

✔️ Ipca Laboratories Q2 net up 63.27% at Rs 193.54 cr
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54cr
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54 cr
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 26-09-2019 To 16-02-2022
-: Stock News :- IPCALAB 26-09-2019 To 16-02-2022

✔️ Pharma company IPCA Labs is building momentum outside US markets
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54cr
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54 cr
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 08-03-2019 To 16-02-2022
-: Stock News :- IPCALAB 08-03-2019 To 16-02-2022

✔️ Optimism on Europe, India biz to offset US sales losses for Ipca Labs
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54cr
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54 cr
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 01-03-2019 To 16-02-2022
-: Stock News :- IPCALAB 01-03-2019 To 16-02-2022

✔️ Ipca Labs stock nears record high, surges 6%; here's what brokerages say
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54cr
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54 cr
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 12-02-2019 To 16-02-2022
-: Stock News :- IPCALAB 12-02-2019 To 16-02-2022

✔️ Ipca Laboratories Q3 net jumps 52% to Rs 160.18 cr
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54cr
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54 cr
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 20-11-2018 To 16-02-2022
-: Stock News :- IPCALAB 20-11-2018 To 16-02-2022

✔️ Nomura raises price target for IPCA Lab
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54cr
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54 cr
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 19-11-2018 To 16-02-2022
-: Stock News :- IPCALAB 19-11-2018 To 16-02-2022

✔️ IPCA Labs (Buy)
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54cr
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54 cr
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 20-10-2018 To 16-02-2022
-: Stock News :- IPCALAB 20-10-2018 To 16-02-2022

✔️ Ipca Laboratories: On the mend
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54cr
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54 cr
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 03-10-2018 To 16-02-2022
-: Stock News :- IPCALAB 03-10-2018 To 16-02-2022

✔️ Ipca Labs arm acquires 80% stake in US-based Bayshore Pharmaceuticals for $10.28 mn
✔️ Ipca Labs arm acquires 80% stake in US-based Bayshore Pharma for $10.286 mn
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54 cr
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 09-08-2018 To 16-02-2022
-: Stock News :- IPCALAB 09-08-2018 To 16-02-2022

✔️ Ipca Labs Q1 net profit at Rs 65 cr on strong sales
✔️ Ipca Labs arm acquires 80% stake in US-based Bayshore Pharma for $10.286 mn
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54 cr
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 09-03-2018 To 16-02-2022
-: Stock News :- IPCALAB 09-03-2018 To 16-02-2022

✔️ Broker's call: Ipca Labs (Buy)
✔️ Ipca Labs arm acquires 80% stake in US-based Bayshore Pharma for $10.286 mn
✔️ Ipca Labs Q3 net profit up 24% to Rs 197.54 cr
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 22-02-2018 To 16-02-2022
-: Stock News :- IPCALAB 22-02-2018 To 16-02-2022

✔️ Ipca Laboratories (662.7)
✔️ Ipca Laboratories (662.7)
✔️ Ipca Labs hits 52-week high; up 21% in 11 days post Q3 results
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 08-02-2018 To 16-02-2022
-: Stock News :- IPCALAB 08-02-2018 To 16-02-2022

✔️ IPCA Labs: Eyes on FDA officials visit
✔️ Ipca Laboratories (662.7)
✔️ Ipca Labs hits 52-week high; up 21% in 11 days post Q3 results
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 17-01-2018 To 16-02-2022
-: Stock News :- IPCALAB 17-01-2018 To 16-02-2022

✔️ Ipca Laboratories buys US API developer Pisgah Labs for $9.65 million
✔️ Ipca Labs' subsidiaries buy Pisgah Labs for $9.65 million
✔️ Ipca Labs hits 52-week high; up 21% in 11 days post Q3 results
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 19-12-2017 To 16-02-2022
-: Stock News :- IPCALAB 19-12-2017 To 16-02-2022

✔️ Over dependence on drug imports from China harmful for India: IPCA
✔️ Ipca Labs' subsidiaries buy Pisgah Labs for $9.65 million
✔️ Ipca Labs hits 52-week high; up 21% in 11 days post Q3 results
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 10-11-2017 To 16-02-2022
-: Stock News :- IPCALAB 10-11-2017 To 16-02-2022

✔️ IPCA Labs: Booster from Global Fund
✔️ Ipca Labs' subsidiaries buy Pisgah Labs for $9.65 million
✔️ Ipca Labs hits 52-week high; up 21% in 11 days post Q3 results
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 20-06-2017 To 16-02-2022
-: Stock News :- IPCALAB 20-06-2017 To 16-02-2022

✔️ Ban in US market due to change in drug shortage situation: IPCA
✔️ Ipca Labs' subsidiaries buy Pisgah Labs for $9.65 million
✔️ Ipca Labs hits 52-week high; up 21% in 11 days post Q3 results
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 18-06-2017 To 16-02-2022
-: Stock News :- IPCALAB 18-06-2017 To 16-02-2022

✔️ Regulatory issues put IPCA earnings at risk
✔️ Ipca Labs' subsidiaries buy Pisgah Labs for $9.65 million
✔️ Ipca Labs hits 52-week high; up 21% in 11 days post Q3 results
✔️ Ipca Labs Q4 net profit declines 13.5% at Rs 83 cr
✔️ IPCA Labs: Does return of pre-COVID expenses derail investment case?

View Full Story
-: Stock News :- IPCALAB 16-06-2017 To 16-06-2017
-: Stock News :- IPCALAB 16-06-2017 To 16-06-2017

✔️ US bans imports of drug from three Ipca Lab facilities; shares fall
✔️ Ipca Lab Shares End Over 8% Lower as USFDA Bans Drug Import
✔️ Ipca Labs Falls 15% As US Regulator Bans Drug Import
✔️ IPCA Labs slumps 15.3% as US FDA bars entry of certain drugs
✔️ Ipca Labs nears 52-week low on USFDA bans import of drugs from three plants
✔️ Ipca Labs slips after USFDA bans import of drugs

View Full Story
-: Stock News :- IPCALAB 11-01-2017 To 16-06-2017
-: Stock News :- IPCALAB 11-01-2017 To 16-06-2017

✔️ Third Party Consultants Helping In Remediation Process: Ipca Labs
✔️ Third party consultants assisting in remediation process: Ipca
✔️ Ipca Labs Falls 15% As US Regulator Bans Drug Import
✔️ IPCA Labs slumps 15.3% as US FDA bars entry of certain drugs
✔️ Ipca Labs nears 52-week low on USFDA bans import of drugs from three plants
✔️ Ipca Labs slips after USFDA bans import of drugs

View Full Story
-: Stock News :- IPCALAB 08-09-2016 To 16-06-2017
-: Stock News :- IPCALAB 08-09-2016 To 16-06-2017

✔️ Today's Pick: IPCA Laboratories (English) by Lavanya Prabhakaran
✔️ IPCA Laboratories (578.1)
✔️ Today's Pick (Tamil): IPCA Laboratories
✔️ IPCA Labs slumps 15.3% as US FDA bars entry of certain drugs
✔️ Ipca Labs nears 52-week low on USFDA bans import of drugs from three plants
✔️ Ipca Labs slips after USFDA bans import of drugs

View Full Story
-: Stock News :- IPCALAB 11-08-2016 To 16-06-2017
-: Stock News :- IPCALAB 11-08-2016 To 16-06-2017

✔️ Ipca Lab gains as Q1 profit more than doubles
✔️ Ipca Labs posts over 2-fold jump in net profit
✔️ Ipca Labs Q1 net zooms over two-fold to Rs 47.57 cr
✔️ IPCA Labs slumps 15.3% as US FDA bars entry of certain drugs
✔️ Ipca Labs nears 52-week low on USFDA bans import of drugs from three plants
✔️ Ipca Labs slips after USFDA bans import of drugs

View Full Story
-: Stock News :- IPCALAB 08-08-2016 To 16-06-2017
-: Stock News :- IPCALAB 08-08-2016 To 16-06-2017

✔️ Buy Ipca Laboratories Ltd., target Rs 560.0 : Sameet Chavan
✔️ Ipca Labs posts over 2-fold jump in net profit
✔️ Ipca Labs Q1 net zooms over two-fold to Rs 47.57 cr
✔️ IPCA Labs slumps 15.3% as US FDA bars entry of certain drugs
✔️ Ipca Labs nears 52-week low on USFDA bans import of drugs from three plants
✔️ Ipca Labs slips after USFDA bans import of drugs

View Full Story
-: Stock News :- IPCALAB 14-08-2022 To 14-08-2022
-: Stock News :- IPCALAB 14-08-2022 To 14-08-2022

✔️ Hold Ipca Laboratories; target of Rs 1010: Prabhudas Lilladher

View Full Story
-: Stock News :- IPCALAB 23-06-2022 To 23-06-2022
-: Stock News :- IPCALAB 23-06-2022 To 23-06-2022

✔️ Buy Ipca Laboratories; target of Rs 1030: Motilal Oswal

View Full Story
-: Stock News :- IPCALAB 16-08-2022 To 16-08-2022
-: Stock News :- IPCALAB 16-08-2022 To 16-08-2022

✔️ Hold Ipca Laboratories: target of Rs 985: ICICI Direct

View Full Story

No More Records...